Table 1 Baseline clinical characteristics
|  | Low HDL (n = 465) | Normal HDL (n = 519) | p-value |
|---|---|---|---|
Age (years) | 64.12 ± 9.91 | 65.10 ± 9.78 | 0.120 |
Male, n (%) | 328 (70.54) | 318 (61.27) | 0.002 |
BMI (kg/m2) | 24.23 ± 3.01 | 24.06 ± 3.02 | 0.301 |
Smoking, n (%) | 164 (35.42) | 166 (31.98) | 0.255 |
Newly diagnosed DM, n (%) | 30 (6.45) | 53 (10.21) | 0.034 |
Hypertension, n (%) | 302 (65.09) | 335 (64.92) | 0.957 |
Dyslipidemia, n (%) | 115 (24.78) | 149 (28.76) | 0.160 |
Previous MI, n (%) | 28 (6.02) | 33 (6.36) | 0.827 |
On Admission | |||
 STEMI, n (%) | 217 (46.67) | 254 (48.94) | 0.476 |
 Primary PCI, n (%) | 280 (60.22) | 318 (61.27) | 0.735 |
 LVEF, n (%) | 50.51 ± 12.31 | 51.00 ± 11.26 | 0.522 |
 Total cholesterol (mg/dL) | 162.92 ± 45.74 | 180.83 ± 44.34 | <.001 |
 Triglyceride (mg/dL) | 151.59 ± 109.69 | 121.63 ± 83.35 | <.001 |
 LDL-C (mg/dL) | 100.97 ± 34.76 | 105.63 ± 45.82 | 0.072 |
 HDL-C (mg/dL) | 32.70 ± 5.22 | 53.8 ± 26.83 | <.001 |
 Creatinine (mg/dL) | 2.16 ± 16.55 | 1.69 ± 11.84 | 0.611 |
 HbA1c (%) | 7.83 ± 1.58 | 7.66 ± 1.49 | 0.111 |
 hsCRP (mg/L) | 6.00 ± 15.69 | 6.01 ± 24.07 | 0.993 |
 Peak CK-MB (ng/mL) | 75.71 ± 120.75 | 85.67 ± 122.03 | 0.202 |
 Maximum Troponin-I (ng/mL) | 28.76 ± 55.53 | 29.71 ± 58.47 | 0.825 |
Medication at discharge | |||
 Aspirin, n (%) | 449 (98.25) | 510 (98.84) | 0.442 |
 Clopidogrel, n (%) | 434 (94.97) | 487 (94.38) | 0.684 |
 Cilostazol, n (%) | 88 (19.26) | 105 (20.35) | 0.670 |
 Beta blocker, n (%) | 394 (85.65) | 437 (84.36) | 0.573 |
 ACEI/ARB, n (%) | 376 (81.74) | 441 (85.14) | 0.153 |
 Statin, n (%) | 381 (82.83) | 452 (87.26) | 0.052 |
 Nitrate, n (%) | 128 (27.83) | 149 (28.76) | 0.745 |
 Insulin, n (%) | 76 (16.52) | 70 (13.51) | 0.188 |